When was Deep 6 AI founded?

Deep 6 AI was founded in 2013 and raised its 1st funding round 3 years after it was founded.

Where is Deep 6 AI located?

Deep 6 AI is headquartered in Pasadena, United States. It is registered at Pasadena, California.

How many employees does Deep 6 AI have?

As of Jun 30, 2026, the latest employee count at Deep 6 AI is 17.

Is Deep 6 AI a funded company?

Deep 6 AI is a funded company, having raised a total of $54.8M across 6 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Apr 04, 2016.

When was the latest funding round of Deep 6 AI?

Deep 6 AI's latest funding was a $***** Series C round on Apr 26, 2022, with participation from 1 investor.

Where does Deep 6 AI rank among its competitors?

Deep 6 AI ranks 30th amongst 314 active competitors, of which 54 are funded. It stands 6th in terms of total funding among its competitors. The most recent competitor to raise funding was Tempus, which secured $460M in Jul, 2026.

Who are the top competitors of Deep 6 AI?

Deep 6 AI's top competitors include Medidata, Verily and IQVIA. Among them, Tempus secured the most recent funding round in July, 2026.

Deep 6 AI - 2026 Company Profile, Team, Funding & Competitors

Company Details

Deep 6 AI (formerly Deep 6 Analytics) develops artificial intelligence enabled solutions for clinical trial use cases. It uses AI technologies to understand the unstructured data from medical records to find more patients for clinical trials easily. It helps hospitals or pharma companies to reduce the onboarding and trail time, reduce record analysis expenses, increase patient outcome, etc.

Website: deep6.ai
Social
Email ID: *****@deep6.ai
Phone Number: +1 **********
Registered Address: Pasadena, California

Key Metrics

Founded Year

2013

Location

Pasadena, United States

Stage

Acquired

Total Funding

$54.8M in 6 rounds

Latest Funding Round

Series C, Apr 26, 2022, $*****

Investors

Point72 Ventures & 12 more

Ranked

30^th among 314 active competitors

Employee Count

17 as on Jun 30, 2026

Similar Companies

Medidata & 2880 more

Exit Details

Acquired by Tempus (Mar 11, 2025)

View Deep 6 AI's full profile

Deep 6 AI is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
DEEP 6 AI INC CIN: 463745750 , United States, Active		-	41 (As on Dec 31, 2019)	-

Deep 6 AI got acquired by Tempus on Mar 11, 2025.

Click here to take a look at Deep 6 AI's acquisition in detail

Deep 6 AI has raised a total funding of $54.8M over 6 rounds. Its first funding round was on Apr 04, 2016. Its latest funding round was a Series C round on Apr 26, 2022 for $*****. 1 investor participated in its latest round. Deep 6 AI has 13 institutional investors.

Here is the list of recent funding rounds of Deep 6 AI:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Apr 26, 2022	4246781	Series C	2945974	4418204	4010674	5180701
Sep 17, 2019	9084498	Series B	4621532	1595549	9864375	GSR Ventures
Nov 29, 2017	7260862	Series A	9117806	3800730	1829141	7714267

Access funding benchmarks and valuations. Sign up today!

View details of Deep 6 AI's funding rounds and investors

The founders of Deep 6 AI are Brian Dolan and Wout Brusselaers.

Here are the details of Deep 6 AI's key team members:

Brian Dolan: Former Co-Founder & CSO of Deep 6 AI.
Wout Brusselaers: Co-Founder & CEO of Deep 6 AI.
Contact Info: 1 email address

View details of Deep 6 AI's Founder profiles and Board Members

Deep 6 AI's employee count trend

Deep 6 AI has 17 employees as of Jun 26. Here is Deep 6 AI's employee count trend over the years:

Uncover Deep 6 AI's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Deep 6 AI include Medidata, Verily and IQVIA. Here is the list of Top 10 competitors of Deep 6 AI, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Medidata 1999, New York City (United States), Acquired	AI-based clinical trial management software for researchers	$41.5M	Insight Partners, TFS & 11 others	86/100
2nd	Verily 2015, Dallas (United States), Series D	A data platform and technology company purpose-built to power AI-enabled precision health	$2.8B	Silver Lake, Temasek & 9 others	82/100
3rd	IQVIA 1982, Durham (United States), Public	Provider of clinical research and commercialization solutions for healthcare	$1.74M	Leonard Green and Partners, Aisling Capital ... & 12 others	80/100
4th	Tempus 2015, Chicago (United States), Public	Developer of genomic testing and artificial intelligence tools for medicine	$1.05B	T. Rowe Price, New Enterprise Associates ... & 11 others	77/100
5th	Signant Health 2000, Plymouth Meeting (United States), Acquired	Provider of a software solution for clinical trial management	$3.4M	Harvest Partners, 3i Group & 4 others	72/100
6th	Science 37 2014, Los Angeles (United States), Acquired	Provider of a suite solution for clinical trials for researchers	$106M	Redmile Group, Lux Capital & 12 others	71/100
7th	TriNetX 2013, Cambridge (United States), Acquired	Provider of clinical trial management software for researchers and professionals	$102M	Merck Global Health Innovation Fund, Thecarlylegroup.fr ... & 6 others	66/100
8th	Wcg Clinical 2012, Princeton (United States), Acquired	CRO offering regulatory and ethical review services for clinical research	-	Ares Capital Corporation, Prospect Capital ... & 6 others	64/100
9th	Viz.ai 2016, San Francisco (United States), Series D	Developer of an AI-powered platform for care coordination and disease detection	$252M	Insight Partners, DHVC & 17 others	64/100
10th	Massive Bio 2014, New York City (United States), Series B	Provider of AI-based clinical trial management tool	$15.6M	Revo Capital, Philips HealthWorks & 8 others	63/100
30th	Deep 6 AI 2013, Pasadena (United States), Acquired	AI enabled solutions for clinical trials	$54.8M	MemorialCare Innovation Fund, GSR Ventures ... & 11 others	51/100